Control and exacerbation of asthma: A survey of more than 3000 French physicians

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 9, 2004, Pages 920-926

  Demoly, P ^a   Crestani, B ^b   Leroyer, C ^c   Magnan, A ^d   Mounedji, N ^e   Humbert, M ^f  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b BICHAT HOSPITAL   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e ASTRAZENECA   (United Kingdom)

^f UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Asthma; Control; Exacerbation; Management; Survey

Indexed keywords

ASTHMA; CLINICAL FEATURE; DISEASE EXACERBATION; DYSPNEA; FRANCE; GENERAL PRACTITIONER; HEALTH SERVICE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INTERVIEW; LUNG FUNCTION TEST; MEDICAL SPECIALIST; PEAK EXPIRATORY FLOW; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SLEEP; SYMPTOMATOLOGY;

ASTHMA; FEMALE; FRANCE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS;

EID: 4344681092     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00520.x     Document Type: Review

References (14)

1. VIGNOLA AM, SCICHILONE N, BOUSQUET J, BONSIGNORE G. BELLIA V. Aging and asthma: pathophysiological mechanisms. Allergy 2003;58:165-175.
2. GARCIA G, ADLER M, HUMBERT M. Difficult asthma. Allergy 2003;58: 114-121.
3. Observatoire national des prescriptions et consommations des médicaments dans les secteurs ambulatoires et hospitaliers. Analyse de l'évolution des prescriptions et des consommations des antiasthmatiques en France en ambulatoire et en milieu hospitalier. Agence Française de Sécurité Sanitaire des Produits de Santé. Juin 2001.
4. COM-RUELLE L, CRESTIN B, DUMESNIL S. L'asthme en France selon les stades de sévérité. Bulletin d'information en économie de la santé. Question d'économie de la santè. Centre de Recherche d'Etude et Documentation en Economie de la Santé (CREDES), 2000: 25.
5. NEUKIRCH F, PIN I, KNANI J, HENRY C, PISON C, LIARD R et al. Prevalence of asthma and asthma-like symptoms in three French cities. Respir Med 1995;89:685-692.
6. GODARD P, CHANEZ P, SIRAUDIN L, NICOLOYANNIS N, DURU G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J 2002;19:61-67.
7. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute, National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol 1991;88:425-534.
8. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. WHO/NHLBI workshop report. National Institute of Health, Heart, Lung and Blood, 2002: http://afssaps.sante.fr.
9. PAUWELS RA, LOFDAHL CG, POSTMA DS, TATTERSFIELD AE, O'BYRNE P, BARNES JP et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411.
10. CHUNG KF, GODARD P, ADELROTH E, AYRES J, BARNES N, BARNES P et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J 1999;13:1198-1208.
11. CORBRIDGE TC, HALL JB. The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med 1995;151:1296-1316.
12. TOELLE BG, RAM FS. Written individualised management plans for asthma in children and adults. Cochrane Database Syst Rev 2002:CD002171: http://www.ginasthma.com.
13. YOON R, MCKENZIE DK, BAUMAN A, MILES DA. Controlled trial evaluation of an education programme for adults. Thorax 1993;48:1110-1116.
14. DE MARCO R, BUGIANI M, CAZZOLETTI L et al. The control of asthma in Italy. A multicentre descriptive study on young adults with doctor diagnosed current asthma. Allergy 2003;58:221-228.